CAREERS
Scientist Position at ATXA Therapeutics Limited
About Us
ATXA Therapeutics Limited (ATXA) is a spin-out company from University College Dublin (UCD), whose primary focus is to advance novel therapies through Phase I – III clinical trials and securement of marketing authorization for the treatment of Pulmonary Arterial Hypertension (PAH).
Job Description
Applications are invited for a scientist with a PhD (or M.Sc) to join an established team of researchers at ATXA, located at the Conway Institute of Biomolecular & Biomedical Research, UCD, Dublin, Ireland.
Qualifications
Mandatory
-
Proven hands-on expertise in cell biology & signalling, with strong experience in molecular biology and mammalian cell culture.
-
Expertise in image analysis and/or histology highly desirable.
-
Ability to learn, and to plan, organize and work to deadlines.
-
Excellent written and oral communication skills, with an ability to prepare scientific reports and presentations deemed essential.
-
Strong competency in data handling & data analysis essential.
-
Capacity to work in new &/or related scientific fields, as well as independently and with other scientists, clinicians &/or funding/industry partners.
-
Experience in drafting manuscripts and preparing for conferences/workshops essential.
-
Ability to assimilate scientific literature, and keep up with same, essential.
Further Details
Salary: The appointment will be made on the entry post-doctoral level (within 5 years following award of PhD) and will be dependent on qualifications and experience. For the right candidate, applicants with an M.Sc meeting the above qualifications may also be considered.
The successful candidate must be available to start on 6th January 2020, and the appointment will initially be for 1 year, pending successful completion of a 3-month probationary period.
Applications (Letter of application, addressing the relevance of your candidacy to the specifications above, CV & full contact details of 3 referees) to: Prof. Therese Kinsella, Chief Scientific Officer, ATXA Therapeutics Limited; Email: Audrey.Murray@atxatherapeutics.com
Closing Date
Friday 6 December 2019